Preclinical studies of GLP-1 pathways have raised questions about inflammation, microglia, astrocytes, and neuroprotection
Romera I, Cebrin-Cuenca A, lvarez-Guisasola F, Gomez-Peralta F, Reviriego J
This natural stimulation helps maintain balanced growth hormone levels and reduces the risk of dependency or significant hormonal imbalances
However, the safest treatment depends on the patient, not the trend
Visit to access subscription buttons for The Pharmacists Voice Podcast
A change in diabetes drug prescribing led to clinical trials of intranasal insulin administration, followed by insulin sensitizers, including metformin and peroxisome proliferator-activated receptor agonists, followed by incretin mimetics targeting primarily GLP-1R (GLP-1RAs) [106]